Canaccord Genuity lowers Idox to hold after shares reach target price

by | Sep 23, 2021

Analysts at Canaccord Genuity downgraded software firm Idox from ‘buy’ to ‘hold’ on Thursday, citing a now “fair” valuation.
Canaccord said Idox management had tidied up the group over the last couple of years across the spectrum of accounting policies, commercial contract management and internal reporting systems.

However, it added that Idox’s share price had now reached its target price, leading it to lower its recommendation and only nudge its target price slightly higher from 70.0p to 75.0p.

The German bank stated that at its modestly raised target price, Idox shares were on a price-to-earnings ratio of around 29 times annualised to December 2022, compared to the rest of the sector at around 33 times.

“We continue to believe a discount of 5 to 10% to sector average is fair given organic sales growth at 5% Vs sector circa 10%. Only a small discount though as Idox has enviable adjusted EBIT margins, at circa 22% est, versus sector at 14%. This margin throws off cash that will likely be used to make further strategic bolt-on acquisitions going forward,” said Canaccord.

“Reflecting this 5 to 10% discount we increase our target slightly to 75.0p/share (the sector average has increased slightly over the last couple of months).”

Related articles

RBC Capital cuts Rentokil price target

RBC Capital cuts Rentokil price target

(Sharecast News) - RBC Capital Markets cut its price target on Rentokil Initial on Wednesday to 575p from 610p as it downgraded forecasts for forex and a greater back-end loading of TMX synergies, but said it believes the long-term story remains intact. The bank said...

Trending stories

Join our mailing list

Subscribe to our mailing list to receive regular updates!

x